Curis
CRIS
#10233
Rank
C$20.65 M
Marketcap
C$1.60
Share price
-10.08%
Change (1 day)
-68.55%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2025 (TTM): C-$5.20

According to Curis's latest financial reports the company's current EPS (TTM) is C-$5.05. In 2024 the company made an earnings per share (EPS) of C-$9.68 an increase over its 2023 EPS that were of C-$12.42.

EPS history for Curis from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C-$5.20-46.28%
2024C-$9.68-22.06%
2023C-$12.42-26.25%
2022C-$16.8422.3%
2021C-$13.77-25.37%
2020C-$18.45-30.93%
2019C-$26.71-2.02%
2018C-$27.26
2016C-$61.96-10%
2015C-$68.84138.1%
2014C-$28.9140%
2013C-$20.65-25%
2012C-$27.5466.67%
2011C-$16.52

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Exelixis
EXEL
C$3.28-164.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C$1.94-138.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
C-$0.50-90.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
C-$4.65-7.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$2.37-146.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$4.09-180.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
C-$15.48 206.27%๐Ÿ‡บ๐Ÿ‡ธ USA